Pnc Financial Services Group, Inc. Biomarin Pharmaceutical Inc Transaction History

Pnc Financial Services Group, Inc.

  • $162 Billion
  • Q3 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 11,257 shares of BMRN stock, worth $616,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,257
Previous 10,747 4.75%
Holding current value
$616,095
Previous $590,000 3.22%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$52.62 - $61.93 $26,836 - $31,584
510 Added 4.75%
11,257 $609,000
Q2 2025

Aug 08, 2025
SELL
$54.08 - $68.32 $111,891 - $141,354
-2,069 Reduced 16.14%
10,747 $590,000
Q1 2025

May 09, 2025
BUY
$61.25 - $72.83 $39,812 - $47,339
650 Added 5.34%
12,816 $905,000
Q4 2024

Feb 07, 2025
BUY
$61.93 - $70.49 $4,706 - $5,357
76 Added 0.63%
12,166 $799,000
Q3 2024

Nov 08, 2024
BUY
$69.02 - $93.84 $215,480 - $292,968
3,122 Added 34.81%
12,090 $849,000
Q2 2024

Aug 09, 2024
BUY
$74.43 - $92.22 $107,700 - $133,442
1,447 Added 19.24%
8,968 $738,000
Q1 2024

May 10, 2024
SELL
$83.81 - $99.0 $57,158 - $67,518
-682 Reduced 8.31%
7,521 $656,000
Q4 2023

Feb 09, 2024
SELL
$76.22 - $98.51 $8,841 - $11,427
-116 Reduced 1.39%
8,203 $790,000
Q3 2023

Nov 13, 2023
SELL
$85.07 - $94.48 $128,370 - $142,570
-1,509 Reduced 15.35%
8,319 $736,000
Q2 2023

Aug 11, 2023
SELL
$86.68 - $100.3 $104,189 - $120,560
-1,202 Reduced 10.9%
9,828 $851,000
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $14,213 - $18,997
-162 Reduced 1.45%
11,030 $1.07 Million
Q4 2022

Feb 10, 2023
SELL
$80.93 - $108.63 $35,851 - $48,123
-443 Reduced 3.81%
11,192 $1.16 Million
Q3 2022

Nov 10, 2022
BUY
$82.16 - $96.94 $65,810 - $77,648
801 Added 7.39%
11,635 $986,000
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $176,698 - $214,693
2,472 Added 29.56%
10,834 $897,000
Q1 2022

May 12, 2022
BUY
$74.28 - $92.69 $78,365 - $97,787
1,055 Added 14.44%
8,362 $644,000
Q4 2021

Feb 11, 2022
SELL
$71.72 - $91.47 $17,858 - $22,776
-249 Reduced 3.3%
7,307 $645,000
Q3 2021

Nov 05, 2021
BUY
$74.77 - $85.47 $65,872 - $75,299
881 Added 13.2%
7,556 $584,000
Q2 2021

Aug 06, 2021
BUY
$75.51 - $84.79 $21,973 - $24,673
291 Added 4.56%
6,675 $556,000
Q1 2021

May 07, 2021
SELL
$74.73 - $90.69 $167,320 - $203,054
-2,239 Reduced 25.97%
6,384 $482,000
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $180,145 - $223,786
2,481 Added 40.39%
8,623 $756,000
Q3 2020

Nov 06, 2020
SELL
$71.87 - $131.03 $8,480 - $15,461
-118 Reduced 1.88%
6,142 $467,000
Q2 2020

Aug 07, 2020
SELL
$79.55 - $124.22 $45,263 - $70,681
-569 Reduced 8.33%
6,260 $772,000
Q1 2020

May 08, 2020
BUY
$71.37 - $96.85 $79,149 - $107,406
1,109 Added 19.39%
6,829 $577,000
Q4 2019

Feb 07, 2020
SELL
$64.27 - $86.37 $1.63 Million - $2.19 Million
-25,331 Reduced 81.58%
5,720 $483,000
Q3 2019

Nov 08, 2019
SELL
$67.4 - $85.11 $306,872 - $387,505
-4,553 Reduced 12.79%
31,051 $2.09 Million
Q2 2019

Aug 09, 2019
SELL
$80.35 - $93.9 $196,134 - $229,209
-2,441 Reduced 6.42%
35,604 $0
Q1 2019

May 10, 2019
SELL
$84.2 - $98.62 $286,785 - $335,899
-3,406 Reduced 8.22%
38,045 $0
Q4 2018

Feb 08, 2019
SELL
$80.14 - $106.07 $10,017 - $13,258
-125 Reduced 0.3%
41,451 $3.53 Million
Q3 2018

Nov 09, 2018
SELL
$93.92 - $105.72 $144,448 - $162,597
-1,538 Reduced 3.57%
41,576 $0
Q2 2018

Aug 10, 2018
BUY
$76.01 - $99.03 $73,045 - $95,167
961 Added 2.28%
43,114 $0
Q1 2018

May 11, 2018
BUY
$77.67 - $92.63 $63,689 - $75,956
820 Added 1.98%
42,153 $0
Q4 2017

Feb 09, 2018
SELL
$80.76 - $95.13 $119,282 - $140,507
-1,477 Reduced 3.45%
41,333 $0
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $3.45 Million - $4.06 Million
42,810
42,810 $0

Others Institutions Holding BMRN

# of Institutions
667
Shares Held
182M
Call Options Held
1.48M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email